Cargando…
The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are highly similar neuropeptides present in several tissues, endowed with immunoregulatory functions and other systemic effects. We previously reported that both neuropeptides reduce viral production i...
Autores principales: | Temerozo, Jairo R., de Azevedo, Suwellen S. D., Insuela, Daniella B. R., Vieira, Rhaíssa C., Ferreira, Pedro L. C., Carvalho, Vinícius F., Bello, Gonzalo, Bou-Habib, Dumith Chequer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008521/ https://www.ncbi.nlm.nih.gov/pubmed/29951068 http://dx.doi.org/10.3389/fimmu.2018.01336 |
Ejemplares similares
-
Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute Toxoplasmosis
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2019) -
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018) -
Pituitary adenylate cyclase activating polypeptide and migraine
por: Zagami, Alessandro S, et al.
Publicado: (2014) -
Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory
por: Gilmartin, Marieke R., et al.
Publicado: (2021) -
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases
por: Solés-Tarrés, Irene, et al.
Publicado: (2020)